Cell Banking Outsourcing Market Size, Share & Trends Analysis Report By Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking), By Cell Type, By Phase, By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global cell banking outsourcing market size was computed at USD 9,869.5 million in 2021 and is anticipated to exhibit a compound annual growth rate (CAGR) of 16.39% from 2022 to 2030. Rising advancement of the cryopreservation and cell banks preparation methodologies, increasing adoption of stem cell therapies, and growing demand for monoclonal antibodies along with effective biopharmaceuticals are the major factors, driving growth of the market. According to CellTrials.org global enrolments of new trials in advanced cell therapy were up almost 30% in the first quarter of 2020. Most of the rise can be associated to cell therapy efforts for treating COVID-19, and over half of those trials for COVID-19 employ umbilical cord MSCs. Hence, the pandemic has created a new market for those companies which are engaged in the manufacturing of MSCs products from donated birth tissues, hence may contribute to the market growth, post pandemic.

Moreover, many of these manufacturers have applied for COVID-19 EUA from the FDA and are partnering with local hospitals to treat COVID-19 patients. For instance, in September 2021, Life Cell’s Mesocel received approval for a clinical trial from DCGI; therapy derived MSC of the umbilical cord tissue set to treat patients with pneumonia, COVID-19, and acute respiratory distress.

The presence of favorable government initiatives for the development of stable cell lines, as well as the introduction of new technology for cell line storage and characterization, are among the critical factors expected to drive market growth in the forecast period. For instance, In December 2021, ‘Vineti’ and ‘Be The Match BioTherapies’ collaborated to develop an integrated supply chain management solution for gene and cell therapy. Such initiatives and collaborations are anticipated to drive growth during the forecast period.

Furthermore, the key players in the market are also involved in research collaborations, in order to reprogram newborn stem cells from umbilical cord blood as well as umbilical cord tissue into iPSCs. These collaborations are also expected to drive the growth of market over the forecast period. For instance, In May 2021, Opsis Therapeutics, FUJIFILM Cellular Dynamics, and Blue Rock Therapeutics entered into strategic research and development to create cell therapies to cure eye diseases. These companies will use their expertise to develop off-the-shelf iPSCs to cure ocular diseases.

According to a recent study led by the Indiana University School of Medicine in March 2022, human-induced pluripotent stem cells improve visual acuity and vascular health. This study is being done in collaboration with Indiana University School of Medicine and five other institutions to investigate a novel regenerative medicine approach to better manage the vascular health complications associated with type 2 diabetes. Such research activities are expected to boost stem cell banking. Additionally, research for the introduction of cry protective agents to preserve the stability of the tissues during cryopreservation is expected to drive the market.

Type Insights

Master cell banking accounted for the largest share of revenue in 2021, as their preparation is a prerequisite for the production and usage of working cell banks. They are preserved for a significantly longer duration, which also attracts the application of high-grade cryopreservation methodologies and equipment thereby further expanding the revenue base for this segment.

Furthermore, master cell banks find applicability in various research and development perspectives for stem cell therapy and gene therapy. Rising incidences of autoimmune diseases and cancer that can be treated by the use of therapies in combination with regenerative medicine is a key factor expected to fuel the growth of this segment, during the forecast period.

Cell Type Insights

Stem cells segment dominated the market with a share of 55.3%in 2021. Stem cells are obtained from cord blood, embryonic, adult, dental, and IPS cells, while non-stem include somatic cells preserved for applications such as tissue engineering and IPS cell development. An increase in research and development activities associated with the applications of stem cells drives the segment growth. For instance, in February 2021, American CryoStem collaborated with BioTherapeutic Labs Corp for the research and development in stem cell.

Cord cell banking accounted significant market share with respect to revenue in 2021 and their large share can be attributed to the rise in the number of cord blood banks and banking services across the globe. Cord blood provides significant advantages, which include serving as a source of hematopoietic stem cells, donor convenience, minimized risk of graft versus host diseases, low risk of viral contamination and immediate availability.

Phase Insights

Based on phase, the market is segmented into bank storage, bank characterization and testing, and bank preparation. Of these, storage accounted for the largest share of revenue owing to sophisticated preservation needs which are essential for proper maintenance of either master or working banks. Additionally, technologically advanced cryopreservation techniques are expected to fuel the growth of this market throughout the forecast period.

Bank storage in cell banking encompasses the preservation of both master and working banking and their respective safety testing. Bank characterization & testing is expected to witness lucrative growth during the forecast period owing to the presence of market players that are involved in providing outsourcing services for bank characterization &testing to different hospitals and clinical research organizations. For instance, Creative Biogene offers a wide-ranging bank characterization service to the customers to safeguard the biosafety and control of biotechnological and biological products.

Regional Insights

North America dominated the market and accounted for the largest market share of 40.69%in 2021 owing to the presence of extensive R&D laboratories and rising incidences of metabolic disorders such as Parkinson’s, Alzheimer’s, and various other types of cancers, which can be treated by gene therapy. The steep rate of increase in the establishment of banking services, which is a sign of rapid change, also contributes to the organizational diversity in the North American healthcare system.

Asia Pacific is expected to grow at an exponential rate throughout the forecast period. This exponential CAGR is credited to the presence of pharmaceutical companies, which are focusing their priorities on the large and relatively untapped populations in Asia.

Low cost of clinical trials and high investments in biotechnology sector is expected to fuel the market growth of this regional market. In May 2022, International Conference on Stem Cell Research and Therapy was held in China, aiming to give a platform for academicians, researchers, industrial professionals to present their research and discuss developments, and advancements in stem cell. Such initiatives by private and government organizations to discuss and support stem cell research is anticipated to help the market grow in this region.

Key Companies & Market Share Insights

Key players in this market are implementing various strategies including partnerships through mergers & acquisitions, geographical expansion, and strategic collaborations to increase their market presence. For instance, in February 2021, Cryo-Cell International, Inc. the world’s first private cord blood bank entered into a collaborative license agreement with Duke University. Through this agreement, the company intends to expand its major business units. Some of the key players in the global cell banking outsourcing market include:

• Bio Reliance

• Bio Outsource (Sartorious)

• BSL Bioservice

• Cryo-Cell International, Inc

• Charles River Laboratories

• Covance

• Global Stem Inc.

• Goodwin Biotechnology Inc.

• Lonza

• SGS Life Sciences

Cell Banking Outsourcing Market Report Scope

Global Cell Banking Outsourcing Market Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global cell banking outsourcing market report based on the type, cell type, phase, and region.

• Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Master Cell Banking

  • Working Cell Banking

  • Viral Cell Banking

• Cell Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Stem Cell

    • Cord Cell Banking

    • Embryonic Stem Cell Banking

    • Adult Stem Cell Banking

    • Dental Stem Cell Banking

    • IPS Stem Cell Banking

  • Non-stem Cell

• Phase Outlook (Revenue, USD Million, 2018 - 2030)

  • Bank Storage

    • Master Cell Bank Storage

    • Working Cell Bank Storage

    • Cell Storage Stability Testing

  • Bank Characterization & Testing

    • Safety Testing

      • Viral Cell Banks

      • Microbial Cell Banks

    • Gene Expression Testing

    • Karyology Testing

    • Gene Sequencing Testing

  • Bank Preparation

    • Master Cell Bank Preparation

    • Working Cell Bank Preparation

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

  • Asia Pacific

    • Japan

    • China

    • India

    • Korea

    • Singapore

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa